BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34256572)

  • 1. Socioeconomic Burden of Rising Methamphetamine-Associated Heart Failure Hospitalizations in California From 2008 to 2018.
    Zhao SX; Deluna A; Kelsey K; Wang C; Swaminathan A; Staniec A; Crawford MH
    Circ Cardiovasc Qual Outcomes; 2021 Jul; 14(7):e007638. PubMed ID: 34256572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methamphetamine-Associated Heart Failure Hospitalizations Across the United States: Geographic and Social Disparities.
    Dickson SD; Thomas IC; Bhatia HS; Nishimura M; Mahmud E; Tu XM; Lin T; Adler E; Greenberg B; Alshawabkeh L
    J Am Heart Assoc; 2021 Aug; 10(16):e018370. PubMed ID: 34365802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and Outcomes of Methamphetamine Abuse Among Veterans With Heart Failure.
    Nishimura M; Ma J; Fox S; Toomu A; Mojaver S; Juang DK; Maisel AS; Thomas IC
    Am J Cardiol; 2019 Sep; 124(6):907-911. PubMed ID: 31311659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Characteristics and Outcomes of Patients With Heart Failure and Methamphetamine Abuse.
    Thomas IC; Nishimura M; Ma J; Dickson SD; Alshawabkeh L; Adler E; Maisel A; Criqui MH; Greenberg B
    J Card Fail; 2020 Mar; 26(3):202-209. PubMed ID: 31618697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methamphetamine-associated heart failure: a systematic review of observational studies.
    Manja V; Nrusimha A; Gao Y; Sheikh A; McGovern M; Heidenreich PA; Sandhu ATS; Asch S
    Heart; 2023 Jan; 109(3):168-177. PubMed ID: 36456204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echocardiographic Parameters and Outcomes in Methamphetamine-Associated Heart Failure: A Propensity Score-Weighted Analysis.
    Kewcharoen J; Chang AK; Parwani P; Fraser G; Bharadwaj A; Seliem A; Tran D; Stoletniy L; Sakr A; Abramov D
    Cardiol Res; 2022 Apr; 13(2):81-87. PubMed ID: 35465084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in Characteristics and Outcomes in Primary Heart Failure Hospitalizations Among Older Population in the United States, 2004 to 2018.
    Minhas AMK; Ijaz SH; Jamal S; Dani SS; Khan MS; Greene SJ; Fudim M; Warraich HJ; Shapiro MD; Virani SS; Nasir K; Khan SU
    Circ Heart Fail; 2022 May; 15(5):e008943. PubMed ID: 35078346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospitalization Trends and Health Resource Use for Adult Congenital Heart Disease-Related Heart Failure.
    Burchill LJ; Gao L; Kovacs AH; Opotowsky AR; Maxwell BG; Minnier J; Khan AM; Broberg CS
    J Am Heart Assoc; 2018 Aug; 7(15):e008775. PubMed ID: 30371225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Burden of Heart Failure Events in the United States, 2006 to 2014.
    Jackson SL; Tong X; King RJ; Loustalot F; Hong Y; Ritchey MD
    Circ Heart Fail; 2018 Dec; 11(12):e004873. PubMed ID: 30562099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Cause-Specific Outcomes Among Individuals With Type 2 Diabetes and Heart Failure in the United Kingdom, 1998-2017.
    Lawson CA; Zaccardi F; McCann GP; Davies MJ; Kadam UT; Khunti K
    JAMA Netw Open; 2019 Dec; 2(12):e1916447. PubMed ID: 31790564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes With Ultrafiltration Among Hospitalized Patients With Acute Heart Failure (from the National Inpatient Sample).
    Yazdanyar A; Sanon J; Lo KB; Joshi AM; Kurtz E; Saqib MN; Islam N; Shah MK; Feldman A; Donato A; Rangaswami J
    Am J Cardiol; 2021 Mar; 142():97-102. PubMed ID: 33285095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics, trends, outcomes, and costs of stimulant-related acute heart failure hospitalizations in the United States.
    Shetty S; Malik AH; Ali A; Yang YC; Briasoulis A; Alvarez P
    Int J Cardiol; 2021 May; 331():158-163. PubMed ID: 33535075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in hospitalization for congestive heart failure, 1996-2009.
    Munir MB; Sharbaugh MS; Thoma FW; Nisar MU; Kamran AS; Althouse AD; Saba S
    Clin Cardiol; 2017 Feb; 40(2):109-119. PubMed ID: 27862089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional differences in heart failure hospitalizations, mortality, and readmissions in Slovenia 2004-2012.
    Omersa D; Erzen I; Lainscak M; Farkas J
    ESC Heart Fail; 2019 Oct; 6(5):965-974. PubMed ID: 31264804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends and characteristics of hospitalizations for heart failure in the United States from 2004 to 2018.
    Salah HM; Minhas AMK; Khan MS; Khan SU; Ambrosy AP; Blumer V; Vaduganathan M; Greene SJ; Pandey A; Fudim M
    ESC Heart Fail; 2022 Apr; 9(2):947-952. PubMed ID: 35098700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kansas City Cardiomyopathy Questionnaire Score Is Associated With Incident Heart Failure Hospitalization in Patients With Chronic Kidney Disease Without Previously Diagnosed Heart Failure: Chronic Renal Insufficiency Cohort Study.
    Mishra RK; Yang W; Roy J; Anderson AH; Bansal N; Chen J; DeFilippi C; Delafontaine P; Feldman HI; Kallem R; Kusek JW; Lora CM; Rosas SE; Go AS; Shlipak MG;
    Circ Heart Fail; 2015 Jul; 8(4):702-8. PubMed ID: 25985796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health care resource utilization among patients with T2D and cardiovascular-, heart failure-, or renal-related hospitalizations.
    Annavarapu S; Ghosh S; Li Y; Moretz C; Shetty S; Prewitt T
    Am J Manag Care; 2020 Jun; 26(6):e166-e171. PubMed ID: 32549065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in HF Hospitalizations Among Young Adults in the United States From 2004 to 2018.
    Jain V; Minhas AMK; Khan SU; Greene SJ; Pandey A; Van Spall HGC; Fonarow GC; Mentz RJ; Butler J; Khan MS
    JACC Heart Fail; 2022 May; 10(5):350-362. PubMed ID: 35483798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in Hospital Admissions for Systolic and Diastolic Heart Failure in the United States Between 2004 and 2017.
    Afzal A; van Zyl J; Nisar T; Kluger AY; Jamil AK; Felius J; Hall SA; Kale P
    Am J Cardiol; 2022 May; 171():99-104. PubMed ID: 35365288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
    Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B
    JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.